Smoking Cessation Med May Also Help Cocaine Dependence - Medscape
Posted by admin / Under VareniclineSmoking Cessation Med May Also Help Cocaine Dependence Medscape February 1, 2012 — The partial agonist varenicline (Chantix, Pfizer), which is commonly used as a smoking cessation treatment, may also be effective in treating cocaine dependence, new research suggests. In a small, randomized study of 37 ... |
Published on Sunday 5th of February 2012 02:52:26 AM
Read more...
High Birth Weight Associated With Schizophrenia - Psychiatric News
Posted by admin / Under VareniclineHigh Birth Weight Associated With Schizophrenia Psychiatric News The group selected from the FDA's Adverse Event Reporting System database from 1998 through September 2010 all serious case reports for varenicline (n=9575), bupropion for smoking cessation (n=1751), and nicotine-replacement products (n=1917). |
Published on Sunday 5th of February 2012 02:52:26 AM
Read more...
Pfizer advertises smoking cessation drug despite health warnings - CMAJ
Posted by admin / Under Varenicline CMAJ | Pfizer advertises smoking cessation drug despite health warnings CMAJ Pharmaceutical giant Pfizer Canada is using a national advertising campaign to persuade Canadians who want to quit smoking to use its smoking cessation drug varenicline (Champix), despite a recent study linking it to serious cardiovascular events. |
Published on Sunday 5th of February 2012 02:52:26 AM
Read more...
Anti-smoking drug ads misleading: CMAJ - London Free Press
Posted by admin / Under VareniclineAnti-smoking drug ads misleading: CMAJ London Free Press By QMI Agency Pfizer started marketing its drug varenicline, brand name Champix, in January 2011, and has continued to expand its publicity campaign since a September study by the Canadian Medical Association Journal concluded it heightens a person's ... |
Published on Sunday 5th of February 2012 02:52:26 AM
Read more...
Practicing 'Rational' Polypharmacy in Psychiatry - Medscape
Posted by admin / Under Varenicline Medscape | Practicing 'Rational' Polypharmacy in Psychiatry Medscape Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 2011;68:1195-206. Shim JC, Jung DU, Jung SS, et al. |
Published on Sunday 5th of February 2012 02:52:26 AM
Read more...
